ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 753769 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 753769; 2) Community: the network communities that were significantly associated with the response to NSC 753769; 3) Molecule: the relationships between components within communities and NSC 753769; 4) MDR: the compounds that were significantly associated with the NSC 753769.

NSC Compound Enrichment Correlation
NSC 175630 Toyocamycin, 6-amino- 0.0202245331784474 -0.16696859
NSC 351710 2-methylellpticinium 0.0202245331784474 0.32460281
NSC 352299 2-methylellpticinium 0.0202245331784474 0.31024911
NSC 357680 BUELLOLIDE 0.0202245331784474 -0.12674904
NSC 362454 4-Pyridazinecarbonitrile, 5,6-bis(4-fluorophenyl)-2,3-dihydro-2-(2-hydroxyethyl)-3-oxo- 0.0202245331784474 -0.0032526236
NSC 363979 Cephalostatin 1 0.0202245331784474 0.11561193
NSC 381866 BAFILOMYCIN DERIV. 0.0202245331784474 -0.21152808
NSC 602610 Null 0.0202245331784474 0.011812493
NSC 658229 Null 0.0202245331784474 -0.34365991
NSC 673799 Hexanoic acid, 6-[(7-methoxy-1-nitro-9-acridinyl)amino]- 0.0202245331784474 -0.22002479
Total:59  Current:20    [First] [Prev] [Next] [Last]